Gold tier: mechanically validated evidence, with its primary source.
206 evidence items · page 5 / 9
505 introductionsFive hundred five SARS-CoV-2 introductions in Kenya between March 2020 and September 2022 were associated with the Omicron variant.
KenyaCOVID-19observed March 2020 – September 2022published 2022The genomic epidemiology of SARS-CoV-2 variants of concern in Kenyaeurope_pmcdocument of 8 observationsDOI 10.1101/2022.10.26.22281446
1,053 casesAmong 14,562 acute respiratory infection cases recruited in coastal Kenya by February 2025, 1,053 (7.2%) tested positive for SARS-CoV-2.
KenyaCOVID-19observed February 2025published 2025Longitudinal Epidemiology and Variant Dynamics of SARS-CoV-2 in Coastal Kenya (2020 - 2025europe_pmcdocument of 8 observations
91.6 %At health facility level, 91.6% of SARS-CoV-2 tests were from individuals without symptoms in the Coastal part of Kenya between 17th March 2020 and 30th June 2021.
KenyaCOVID-19observed 17th March 2020 to 30th June 2021published 2022Wellcome open researcheurope_pmcdocument of 10 observations
11 %11% of people living with HIV in Kibera did not access health facilities due to fear of contracting COVID-19, government regulations, and lack of personal protective equipment.
KenyaCOVID-19 · VIH/sidapublished 2021International journal of environmental research and public healthPubMeddocument of 7 observations
17,975 casesAs of July 30, 2020, Kenya reported 17975 cases of COVID-19.
KenyaCOVID-19observed July 30, 2020published 2022Journal of global healthPubMeddocument of 24 observations
66 %SARS-CoV-2 seropositivity was found in 66% of the 126 mothers in Nairobi, Kenya.
KenyaCOVID-19observed between May 1, 2020-February 1, 2022published 2023PloS onePubMeddocument of 8 observations
29 introductionsTwenty-nine SARS-CoV-2 introductions in Kenya between March 2020 and September 2022 were associated with the A.23.1 variant.
KenyaA.23.1 variant · COVID-19observed March 2020 – September 2022published 2022The genomic epidemiology of SARS-CoV-2 variants of concern in Kenyaeurope_pmcdocument of 8 observationsDOI 10.1101/2022.10.26.22281446
1.99 odds_ratioThe odds of developing COVID-19 symptoms were higher among cases aged above 60 years (odds ratio = 1.99, P = 0.007).
KenyaCOVID-19published 2022Journal of global healthPubMeddocument of 24 observations
The FY.4 variant led to a large local outbreak in Kenya.
KenyaCOVID-19published 2025Virus evolutioneurope_pmcdocument of 4 observations
1.37 aORSRI patients presenting with cough were more likely to have SARS-CoV-2 infection compared to those who did not, with an adjusted odds ratio of 1.37.
KenyaCOVID-19observed July 2022 to October 2023published 2026VaccinePubMeddocument of 8 observations
10.3 %SARS-CoV-2 prevalence was 10.3% among people living without HIV and 6.3% among persons living with HIV in Kenya, Uganda, Tanzania, and Nigeria between 19 July 2022 and 1 March 2024.
Kenya · Nigeria · Ouganda · TanzanieCOVID-19observed 19 July 2022 to 1 March 2024published 2025BMC infectious diseasesPubMeddocument of 8 observations
6 mgDexamethasone six milligrams once daily for ten days has demonstrated mortality benefit in severe and critical COVID-19 infection.
KenyaCOVID-19published 2024PloS onePubMeddocument of 18 observations
78 introductionsSeventy-eight SARS-CoV-2 introductions in Kenya between March 2020 and September 2022 were associated with the Beta variant.
KenyaCOVID-19observed March 2020 – September 2022published 2022The genomic epidemiology of SARS-CoV-2 variants of concern in Kenyaeurope_pmcdocument of 8 observationsDOI 10.1101/2022.10.26.22281446
6.3 %SARS-CoV-2 prevalence was 6.3% among persons living with HIV in Kenya, Uganda, Tanzania, and Nigeria between 19 July 2022 and 1 March 2024.
Kenya · Nigeria · Ouganda · TanzanieCOVID-19observed 19 July 2022 to 1 March 2024published 2025BMC infectious diseasesPubMeddocument of 8 observations
45 introductionsLineage B.1 accounted for 45 of the 76 SARS-CoV-2 introductions into Kenyan coast.
KenyaB.1 lineage · COVID-19published 2020Tracking the introduction and spread of SARS-CoV-2 in coastal Kenyaeurope_pmcdocument of 3 observationsDOI 10.21203/rs.3.rs-93975/v1
11 days90 (11%) of hospitalized SARS-CoV-2-infected patients were admitted to the Intensive Care Unit (ICU) for a mean of 11 days.
KenyaCOVID-19published 2022BMJ openPubMeddocument of 7 observations
73.3 %Among 2796 reviewed COVID-19 case records in Kenya, 2049 (73.3%) were male.
KenyaCOVID-19published 2022Journal of global healthPubMeddocument of 24 observations
74 %Lineage B.1 accounted for 74% of sequenced SARS-CoV-2 cases in coastal Kenya between 17th March and 31st July 2020.
KenyaCOVID-19observed 17th March and 31st July 2020published 2021Nature communicationseurope_pmcdocument of 2 observations
6.8 %Prevalence at first nasal swab of SARS-CoV-2 was 6.8% among participants in Kenya, Uganda, Tanzania, and Nigeria between 19 July 2022 and 1 March 2024.
Kenya · Nigeria · Ouganda · TanzanieCOVID-19observed 19 July 2022 to 1 March 2024published 2025BMC infectious diseasesPubMeddocument of 8 observations
68 %In the sample of 582 patients admitted with laboratory-confirmed COVID-19, 68% were men.
KenyaCOVID-19published 2022PloS onePubMeddocument of 7 observations
1.32 aORSRI patients who had HIV were more likely to have SARS-CoV-2 infection compared to those who did not, with an adjusted odds ratio of 1.32.
KenyaCOVID-19 · VIH/sidaobserved July 2022 to October 2023published 2026VaccinePubMeddocument of 8 observations
38.4 %Vaccine efficacy against asymptomatic SARS-CoV-2 infection was 38.4%.
KenyaCOVID-19published 2023Wellcome open researcheurope_pmcdocument of 4 observations
25 %Around 25% of the SARS-CoV-2 genomes from high-income countries were submitted within 21 days.
KenyaCOVID-19published 2022Nature communicationseurope_pmcdocument of 4 observations
73 %COVID-19 vaccination coverage was 73% among a sample of 115 pregnant women in Kenya.
KenyaCOVID-19observed 2022published 2024International journal of environmental research and public healtheurope_pmcdocument of 5 observationsDOI 10.3390/ijerph21010098
52 casesAmong 97 SARS-CoV-2 cases in Laikipia county, Kenya, the Delta variant was detected in 52 cases.
KenyaCOVID-19observed 24th April to 31st December 2021published 2023Temporal distribution and clinical characteristics of the Alpha, Delta and Omicron SARS-Coeurope_pmcdocument of 10 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.